VentriPoint Diagnostics Ltd. VPT.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.52% | -22.03% | 84.36% | 25.27% | 83.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.52% | -22.03% | 84.36% | 25.27% | 83.71% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 10.52% | -22.03% | 84.36% | 25.27% | 102.93% |
| SG&A Expenses | -41.66% | -24.75% | -20.01% | -19.81% | -6.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.63% | -31.07% | -28.39% | -26.24% | -15.36% |
| Operating Income | 43.28% | 31.40% | 30.63% | 27.64% | 16.78% |
| Income Before Tax | 48.47% | 37.33% | 36.31% | 20.91% | 9.99% |
| Income Tax Expenses | 37.25% | 37.25% | 37.25% | -- | -- |
| Earnings from Continuing Operations | 48.67% | 37.33% | 36.29% | 22.50% | 11.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.67% | 37.33% | 36.29% | 22.50% | 11.60% |
| EBIT | 43.28% | 31.40% | 30.63% | 27.64% | 16.78% |
| EBITDA | 67.38% | 42.90% | 30.64% | 27.63% | 16.73% |
| EPS Basic | 53.43% | 40.09% | 37.89% | 24.79% | 13.56% |
| Normalized Basic EPS | 40.00% | 27.41% | 25.00% | 22.30% | 11.56% |
| EPS Diluted | 53.43% | 40.09% | 37.89% | 24.79% | 13.56% |
| Normalized Diluted EPS | 40.00% | 27.41% | 25.00% | 22.30% | 11.56% |
| Average Basic Shares Outstanding | 10.56% | 6.83% | 3.93% | 3.60% | 2.15% |
| Average Diluted Shares Outstanding | 10.56% | 6.83% | 3.93% | 3.60% | 2.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |